Alcon UK and Ireland announces launch of Clareon® PanOptix® Pro

4 June 2026

- Sponsored Content -

Alcon UK and Ireland announces launch of Clareon® PanOptix® Pro: Delivering a Light Experience Like Never Before in a Trifocal IOL1-7 , ¥ – now with less light scatter1,2,8-9 , *

Clareon® PanOptix® Pro delivers:

• More light utilisation, less light scatter1,8*
• Clinically proven low visual disturbance profile10,15**
• Excellent spectacle independence at all distances11*,¥
• High levels of patient9**,† and surgeon satisfaction12-14†† reported

Clareon® PanOptix® Pro and Toric are commercially available in the UK and Ireland, offering powers ranging from +6.0 to +30.0 diopters (in 0.5D increments) in the single-use Clareon® AutonoMe® preloaded delivery system and from +31.0 through +34.0 diopters (in 1.0D increments) in the Clareon® Monarch® IV delivery system.

Learn more about Clareon® PanOptix® Pro at
https://www.myalcon.com/uk/professional/cataract-surgery/iols/clareon-panoptix-pro/
and contact an Alcon representative to experience the power of Pro.

¥ Based on manufacturer reported values and respective methodology for trifocal IOLs Clareon PanOptix, Envista Envy, AT Elana, Gemetric and Rayner.

* Compared to Clareon® PanOptix®. PanOptix® has 88% light utilisation (12% scatter light)/PanOptix® Pro 94% light utilisation (6% scatter light).

** AcrySof® IQ PanOptix® was tested. AcrySof® IQ PanOptix® and Clareon® PanOptix® are optically equivalent.

† Response to the following question on IOLSAT questionnaire (Version 1.0, December 20, 2018) at 6 months post-op "Given your vision today, if you had to do it all over, would you have the same lenses implanted again?"; n=127.

†† USA Market Research Q2, 2024, n=100 cataract surgeons; Question: If you were to undergo cataract surgery yourself, tomorrow, which IOL would you choose? Please select one product.

References:

1. Alcon data on file, 2025. REF-25218
2. Alcon data on file, 2015. REF-08546
3. Muzychuk, A. Defocus Curve Performance of a Novel Hydrophobic Acrylic Trifocal Intraocular Lens: A prospective, Multicenter Canadian Study. ASCRS Annual Meeting, April 5-8, Boston.
4. Rayner Professional Website.
https://rayner.com/en/iol/trifocal/rayone-trifocal/.
Accessed September 2024.
5. Carones F. New Concept of Light Distribution for Bilateral Trifocal IOL Implantation. AAO. 2022;2022:53.
6. ZEISS AT LISA tri family. Supplement in Cataract and Refractive Surgery Today (Europe), September 2014.
7. Zeiss Cataract Insights: Laying the Myth or Reality; Digitalization enhances cataract surgery? Supplement in Ophthalmology Times, Europe; May 22, 2024; https://europe.ophthalmologytimes.com/zeisscataract insight-series?page=1
Accessed September 2024.
8. Alcon data on file, 2024. REF-25221
9. Alcon data on file, 2024. REF-25218
10. Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
11. Zhu D, Ren S, Mills K, Hull J, Dhariwal M. Rate of complete spectacle independence with a trifocal intraocular lens: A systematic literature review and meta-analysis. Ophthalmology and Therapy. 2023;12(2):1157-1171. doi:10.1007/s40123-023-00657-5.
12. Alcon data on file, 2024. REF-25408
13. Alcon data on file, 2024. REF-24102
14. MarketScope LLC. 2023 IOL Market Report: Global Analysis for 2022 to 2028. St. Louis, MO: MarketScope LLC; 2023.
15. Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL. Product Information. 2021

Please refer to the product operator manual or product directions for use for a full list of indications, contraindications and warnings. Available at ifu.alcon.com